Literature DB >> 31766073

Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.

Jorge Magdaleno-Tapial1, Cristian Valenzuela-Oñate1, Marta García-Legaz-Martínez1, Álvaro Martínez-Domenech1, Amparo Pérez-Ferriols1.   

Abstract

Dupilumab, a biologic drug approved for the treatment of moderate-to-severe atopic dermatitis, has been associated with resolution or improvement in pre-existing alopecia areata. We report a case of significant improvement of AA after Dupilumab-onset treatment for atopic dermatitis and review the literature.
© 2019 The Australasian College of Dermatologists.

Entities:  

Keywords:  alopecia areata; dupilumab; treatment

Year:  2019        PMID： 31766073     DOI： 10.1111/ajd.13208

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


  2 in total

1.  Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.

Authors:  Maurizio Romagnuolo; Mauro Barbareschi; Simona Tavecchio; Luisa Angileri; Silvia Mariel Ferrucci
Journal:  Skin Appendage Disord       Date:  2021-07-27

2.  Short communication: Comments on hair disorders associated with dupilumab based on VigiBase.

Authors:  Sunny Park; So Hyang Park; Young Joo Byun; Soo An Choi
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.